| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/25/2009 | EP1075277B1 Methods for detecting and inhibiting angiogenesis |
| 02/25/2009 | CN101374555A Methods for measuring the metabolism of neurally derived biomolecules in vivo |
| 02/25/2009 | CN101371800A Sensor permitting detection of a substance in the body of a living being |
| 02/25/2009 | CN101371788A Quantifying absorption of radiotracer for positron-emission-tomography measurement |
| 02/24/2009 | US7495435 Method for the hyperpolarisation of atomic nuclei and device for implementing the method |
| 02/24/2009 | US7495115 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer |
| 02/24/2009 | US7494666 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 02/24/2009 | US7494642 Fatty acid derivatives; tissue-targeted therapy; tomography; cardiovascular disorders; liver disorders; kits |
| 02/24/2009 | CA2355888C Blood pool agents for nuclear magnetic resonance diagnostics |
| 02/24/2009 | CA2196900C Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells |
| 02/20/2009 | CA2597963A1 Method of providing readily available cellular material derived from peripheral blood and a composition thereof |
| 02/19/2009 | WO2009023745A1 Mesocellular oxide foams as hemostatic compositions and methods of use |
| 02/19/2009 | WO2009022756A1 Diagnosis and treatment of ischemic disease |
| 02/19/2009 | WO2009022279A2 Quinoline as contrast agent in laser induced fluorescence (lif) for lesions |
| 02/19/2009 | WO2009022003A1 Device and procedure for the diagnosis or diagnostic preparation and/or therapy monitoring of inflammatory diseases such as rheumatoid arthritis |
| 02/19/2009 | WO2009021948A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 02/19/2009 | WO2009021947A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 02/19/2009 | WO2009021600A1 Detection of the human vascular endothelial growth factor |
| 02/19/2009 | WO2008148546A3 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 02/19/2009 | WO2007113721A3 Systems and methods for cell measurement utilizing ultrashort t2* relaxometry |
| 02/19/2009 | WO2007039858A3 Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition |
| 02/19/2009 | US20090048331 Methods and formulations for the delivery of pharmacologically active agents |
| 02/19/2009 | US20090047220 Contrast medium for administration to a patient for magnetic resonance imaging |
| 02/19/2009 | US20090047219 Visible to near-infrared light probe using energy transfer between luciferase and an organic dye via a sugar chain |
| 02/19/2009 | US20090047218 Method for producing albumin conjugates comprising an X-ray contrast medium as the active substance |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | US20090047216 Tumor vasculature markers and methods of use thereof |
| 02/19/2009 | US20090047212 Urothelial differentiation of urothelial carcinoma: a bladder cancer stem cell model |
| 02/19/2009 | DE112007001058T5 Elektrisch verstellbares Getriebe mit mehreren verbundenen Zahnradsätzen Electrically variable transmission having a plurality of connected gear sets |
| 02/19/2009 | DE102007036570A1 Screeningtest zur Erkennung von Prostataerkrankungen sowie Vorrichtung und Diagnosesubstanz zur Durchführung des Tests Screening test for the detection of prostate disease as well as apparatus and diagnostic substance for carrying out the test |
| 02/19/2009 | CA2696557A1 Device and procedure for the diagnosis or diagnostic preparation and/or therapy monitoring of inflammatory diseases such as rheumatoid arthritis |
| 02/18/2009 | EP2025350A2 Determining pH by CEDST MRI |
| 02/18/2009 | EP2025349A2 Fluorescent contrast agents |
| 02/18/2009 | EP2025345A1 KIM-1 antagonists and use to modulate immune system |
| 02/18/2009 | EP2023944A2 Pre-b cell proliferation and lymphoblastic leukemia/high-grade lymphoma in mir155 transgenic mice |
| 02/18/2009 | EP2023813A2 Magnetic microparticles comprising organic substances |
| 02/18/2009 | EP2023735A2 Use of nogo receptor-1 (ngr1) antagonists for promoting oligodendrocyte survival |
| 02/18/2009 | EP1909852A4 Amyloid beta protein channel structure and uses thereof indentifying potential drug molecules for neurodegenerative diseases |
| 02/18/2009 | EP1740223A4 Method for characterizing the oxidative stress protective capacity of an antioxidative substance |
| 02/18/2009 | CN201194800Y Automatic detection instrument for animal injury behavior movement |
| 02/18/2009 | CN101370497A Combination therapy with PARP inhibitors |
| 02/18/2009 | CN101370479A Nanoclusters for delivery of therapeutics |
| 02/18/2009 | CN101366953A Small numerator modified iron oxide nano-granule freeze-dried powder for injection and preparation method thereof |
| 02/18/2009 | CN101366952A Magnetic resonance imaging contrast agent |
| 02/18/2009 | CN101366951A Rat model of intrinsic heat blood stasis syndrome |
| 02/18/2009 | CN101366628A Tentaculum electric potential method for dark branchia cockchafer with lamelliform tentaculum |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491501 Methods for identifying modulators of intracellular aggregate formation |
| 02/17/2009 | US7491395 Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination |
| 02/17/2009 | US7491381 screening of therapeutic agents for obesity or emaciation is performed utilizing the nature of long chanin fatty acid elonage gene or protein. |
| 02/17/2009 | US7491312 rapid and efficient method of identifying therapeutic compounds, by allowing only the most favorable molecules initially selected based on their core structure and their physical-chemical characteristics to be further assayed |
| 02/12/2009 | WO2009019196A1 Screening test for recognizing prostate diseases and apparatus and diagnosis substance for carrying out the test |
| 02/12/2009 | WO2009019188A1 Diagnostic substance for use in a method for determining the aggressiveness of a prostate tumor and diagnostic method |
| 02/12/2009 | WO2009019019A2 Production of targeted mri probes by biocompatible coupling of macromolecules with charged nanoparticles |
| 02/12/2009 | WO2008094178A3 Models for vaccine assessment |
| 02/12/2009 | US20090041674 Targeted iron oxide nanparticles |
| 02/12/2009 | US20090041673 Thermally Crosslinked Contrast Agents |
| 02/12/2009 | US20090041672 Drug for Treating or Diagnosing Vascular Lesion in the Skin or the Subcutaneous Soft Tissue Caused by Light Irradiation |
| 02/12/2009 | US20090041671 Protein cages for the delivery of medical imaging and therapeutic agents |
| 02/12/2009 | US20090041670 Near Infrared Fluorescent Contrast Agent And Method For Fluorescence Imaging |
| 02/12/2009 | US20090041668 Non-invasive localization of a light-emitting conjugate in a mammal |
| 02/12/2009 | US20090041667 Treatment of Depressive Disorders |
| 02/12/2009 | US20090041666 Ophthalmic formulations of Amyloid-beta contrast agent and methods of use thereof |
| 02/12/2009 | US20090041665 Method for gene delivery to neuronal cells |
| 02/12/2009 | US20090041661 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
| 02/11/2009 | EP2022508A1 Production of targeted MRI probes by biocompatible coupling of macromolecules with charged nanoparticles |
| 02/11/2009 | EP2021505A2 Men1 is a marker and therapeutic target for breast and prostate cancer |
| 02/11/2009 | EP2021415A2 Dye compounds and the use of their labelled conjugates |
| 02/11/2009 | EP2021317A1 Contrast agents |
| 02/11/2009 | EP2021018A2 Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance |
| 02/11/2009 | EP1701978B1 Use of soluble T-Cadherin for the treatment of metabolic disorders |
| 02/11/2009 | EP1241986B1 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 02/11/2009 | EP1181386B1 Detection of viral stability |
| 02/11/2009 | CN101365712A Pan-her antagonists and methods of use |
| 02/11/2009 | CN101365496A Targeted nanoparticles for magnetic resonance imaging |
| 02/11/2009 | CN101365495A Composition comprising magnetic iron oxide particles and use thereof in medical imaging |
| 02/11/2009 | CN101362066A Preparation method of liposome embedded quantum dots silicon dioxide microspheres and products thereof |
| 02/11/2009 | CN101361679A Establish method of cerebral hemorrhage mold of cynomolgus monkey |
| 02/11/2009 | CN100460019C Microparticles comprising carbohydrate beads covalently linked with allergen |
| 02/10/2009 | US7489964 Electroencephalography based systems and methods for selecting therapies and predicting outcomes |
| 02/10/2009 | US7488844 Therapeutic agents |
| 02/10/2009 | US7488468 Water solubility, reduced toxicity; photodynamic therapy; administering near infrared fluorescent contrast agent , exposing to an excitation light, and detecting near infrared fluorescence from the contrast agent |
| 02/10/2009 | US7488467 Mutating animal model and using phenotypic aberrations to detect defects in processing and metabolism of phosphatides and nitrobenzoxadiazole cholesterol (NBD); treatment of liver and cardiovascular disorders; antitumor/inflammatory agents |
| 02/10/2009 | US7488466 Preparation for determining pyrimidine metabolic capacity |
| 02/10/2009 | CA2223522C Use of 5-aminolevulinic acid for treating or detecting rapidly growing cells of exogenous origin |
| 02/05/2009 | WO2009018368A1 Combination treatment of nmda (n-methyl-d-aspartate)-enhancer, glycine transporter inhibitor, d-amino acid oxidase inhibitor (daaoi) for neuropsychiatric disorders |
| 02/05/2009 | WO2009018335A2 Targeting brain cells via ophtalmic delivery |
| 02/05/2009 | WO2009016718A1 Diagnostic agent and diagnostic method using the same |
| 02/05/2009 | WO2009016181A2 Optical imaging agents |
| 02/05/2009 | WO2009016180A2 Peptide imaging agents |
| 02/05/2009 | WO2008104203A3 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 02/05/2009 | US20090035352 Drug Delivery Particle |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035223 Biomimetic iron-oxide-containing lipoprotein and related materials |
| 02/05/2009 | US20090035222 Techniques for Identifying Molecular Structures and Treating Cell Types Lining a Body Lumen Using Fluorescence |
| 02/05/2009 | US20090035221 Methods and Compositions for Treatment of Erectile Dysfunction |
| 02/05/2009 | US20090035220 high throughput screening system and method |
| 02/05/2009 | US20090035219 CB1 receptor antagonists and uses thereof |
| 02/05/2009 | US20090035218 Systems and methods for tissue imaging |